ASH 2019 Updates on Treatment of Young 'Fit' CLL Pts: Improved PFS and OS With Ibrutinib + Rituximab & iFCG Regimen Effective for Pts With IGHV Mutations

718 views
March 20, 2020
0 Comments
Login to view comments. Click here to Login
Annual Updates from ASH 2019